SARS-CoV-2-IN-13
Product Specifications
CAS Number
56961-10-5
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Purity
0.9854
Bioactivity
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide, displaying greater stability in human plasma and liver S9 enzymes assay. It improves bioavailability and half-life when administered orally and is a potent SARS-CoV-2 inhibitor with an IC50 of 0.057 μM [1].
Smiles
Oc1ccc(Cl)cc1C(=O)Nc1ccc(c(Cl)c1)[N+]([O-])=O
Molecular Formula
C13H8Cl2N2O4
Molecular Weight
327.12
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-EL-H0068-01 24 Tests
Human FASL/TNFSF6 (Factor Related Apoptosis Ligand) ELISA Kit
Sign In for Pricing
View Details E-EL-H0068-02 48 Tests
Human FASL/TNFSF6 (Factor Related Apoptosis Ligand) ELISA Kit
Sign In for Pricing
View Details E-EL-H0068-03 96 Tests
Human FASL/TNFSF6 (Factor Related Apoptosis Ligand) ELISA Kit
Sign In for Pricing
View Details 
